DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Velcade (Bortezomib) - Hypotension - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypotension (108)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 108   Next >>

Possible Velcade side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Hypotension

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalidomide
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-08-06
    End date: 2012-08-09

Velcade
    Dosage: 1 mg/m2, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-08-06
    End date: 2012-08-09

Other drugs received by patient: Dexamethasone



Possible Velcade side effects in

Reported by a physician from France on 2012-08-23

Patient:

Reactions: Back Pain, Electrocardiogram QT Prolonged, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Acetaminophen; Zelitrex / 01269701 /; Fentanyl; Atracurium Besylate; Kardegic / 00002703 /; Oxycontin; Oxygen; Tranxene; Primperan / 00041901 /; Bumetanide; Crestor; Primperan / 00041901 /; Hydrocortisone; Ondansetron; Ondansetron; Ondansetron; Importal; Tramadol HCL; Noradrenaline / 00127501 /; Tramadol HCL; Morphine; Furosemide; Midazolam; Tramadol HCL



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22

Patient: male, weighing 86.2 kg (189.6 pounds)

Reactions: Vomiting, Nausea, Hypotension, Systemic Inflammatory Response Syndrome, Pyrexia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in female

Reported by a physician from United States on 2012-08-20

Patient: female, weighing 70.8 kg (155.8 pounds)

Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Decadron Phosphate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Doxil
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Methotrexate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-01-01

PEG-Asparaginase
    Dosage: day 2, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-25
    End date: 2007-10-25

Velcade
    Dosage: day 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Vincristine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23



Possible Velcade side effects in 14 year old male

Reported by a physician from United States on 2012-08-20

Patient: 14 year old male, weighing 71.4 kg (157.1 pounds)

Reactions: Dyspnoea, Hypotension, Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-10

Cytarabine
    Dosage: 70 mg, cyclic
    Start date: 2012-08-09
    End date: 2012-08-09

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-09

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-09

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-09



Possible Velcade side effects in

Reported by a physician from France on 2012-08-16

Patient:

Reactions: Electrocardiogram QT Prolonged, Back Pain, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Bumetanide; Acetaminophen; Morphine; Atracurium Besylate; Ondansetron; Crestor; Fentanyl; Furosemide; Midazolam; Tranxene; Ondansetron; Tramadol HCL; Noradrenaline / 00127501 /; Hydrocortisone; Importal; Tramadol HCL; Kardegic / 00002703 /; Primperan / 00041901 /; Primperan / 00041901 /; Tramadol HCL; Zelitrex / 01269701 /; Oxycontin; Oxygen; Ondansetron



Possible Velcade side effects in female

Reported by a physician from United States on 2012-08-14

Patient: female, weighing 70.8 kg (155.8 pounds)

Reactions: Abdominal Pain, Rhabdomyolysis, Hyperpyrexia, Chills, Anaphylactic Reaction, Bone Pain, Hepatic Failure, Transaminases Increased, Loss of Consciousness, Aortic Thrombosis, Splenic Infarction, Hypokalaemia, Malaise, C-Reactive Protein Increased, Dyspnoea, Hypotension, Hypophosphataemia, Zygomycosis, Bacteraemia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Lung Infiltration, Shock, Infusion Related Reaction

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 70 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-10-23

Decadron Phosphate
    Dosage: 9 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Methotrexate Sodium
    Dosage: unk, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-01-01

Pegaspargase
    Dosage: unk, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-25

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Vincristine
    Dosage: 2 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23



Possible Velcade side effects in female

Reported by a physician from United States on 2012-08-10

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Pneumonia Fungal, Dyspnoea, Hypotension, Muscular Weakness, Febrile Neutropenia, Hypokalaemia, Dehydration, Hypoxia, Pulmonary Oedema, Hypoalbuminaemia, Neutrophil Count Decreased, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06



Possible Velcade side effects in male

Reported by a physician from United States on 2012-08-09

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Abdominal Pain, Atelectasis, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Activated Partial Thromboplastin Time Prolonged, Multi-Organ Failure, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Alanine Aminotransferase Increased, Hypotension, Hypercalcaemia, Respiratory Failure, Embolism, Cardiac Failure, Aspartate Aminotransferase Increased, Ventricular Tachycardia, Ejection Fraction Decreased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 100 mg/kg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Velcade side effects in

Reported by a physician from United Kingdom on 2012-08-08

Patient:

Reactions: Hypotension, Autonomic Neuropathy, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Zimovane; Difene; Oxycontin; Allopurinol



Possible Velcade side effects in

Reported by a physician from United Kingdom on 2012-07-27

Patient:

Reactions: Pneumocystis Jiroveci Pneumonia, Neutropenic Sepsis, Hypotension, Dehydration, Pulmonary Oedema, Psittacosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1600 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-05-30

Doxorubicin Hydrochloride
    Dosage: 105 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-05-30

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Mantle Cell Lymphoma
    Start date: 2008-05-30

Velcade
    Dosage: 3.3 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-05-30
    End date: 2008-09-03

Vincristine
    Dosage: 2 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-05-30

Other drugs received by patient: Oramorph SR; Acyclovir; Enoxaparin Sodium; Acyclovir; Acetaminophen; Amitriptyline Hydrochloride; Gabapentin



Possible Velcade side effects in 17 year old male

Reported by a physician from United States on 2012-07-26

Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)

Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Pulmonary Oedema, Acute Respiratory Distress Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: 1000 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-27

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Daunorubicin Hydrochloride
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-26



Possible Velcade side effects in male

Reported by a physician from United States on 2012-07-24

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Atelectasis, Abdominal Pain, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Multi-Organ Failure, Activated Partial Thromboplastin Time Prolonged, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Hypotension, Alanine Aminotransferase Increased, Hypercalcaemia, Embolism, Cardiac Failure, Respiratory Failure, Ventricular Tachycardia, Ejection Fraction Decreased, Aspartate Aminotransferase Increased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Cytarabine
    Dosage: 100 mg/kg, bid
    Start date: 2012-06-01
    End date: 2012-06-03

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-21

Patient: male, weighing 87.7 kg (192.9 pounds)

Reactions: Pneumonia, Haemoptysis, Hypotension, Hyponatraemia, Fall, Dehydration, Dizziness, Hypocalcaemia, Asthenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2011-05-17

Zometa
    Dosage: 2 mg, unk
    Indication: Bone Loss
    Start date: 2011-05-13

Other drugs received by patient: Decadron; Vicodin; Coumadin; Dulcolax; Fentanyl; Polyethylene Glycol; Fleet Enema / 00103901 /; Digoxin; Dexamethasone



Possible Velcade side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Abdominal Pain, Acidosis, Pericardial Effusion, Left Ventricular Dysfunction, Hypocalcaemia, Renal Failure Acute, Pneumonitis, Dyspnoea, Angina Pectoris, Hypotension, Anaemia, Delirium, Tumour Lysis Syndrome, Respiratory Failure, Cardiac Failure, Aspartate Aminotransferase Increased, Ejection Fraction Decreased, Sinus Tachycardia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 100 mg/kg, bid
    Start date: 2012-06-01
    End date: 2012-06-03

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient: male, weighing 86.2 kg (189.6 pounds)

Reactions: Vomiting, Nausea, Hypotension, Systemic Inflammatory Response Syndrome, Pyrexia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-04-17
    End date: 2012-04-24

Velcade
    Dosage: 2.3 mg, unk
    Start date: 2012-05-04



Possible Velcade side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient: female, weighing 59.0 kg (129.7 pounds)

Reactions: Vomiting, Fatigue, Nausea, Oesophagitis, Dehydration, Urinary Tract Infection, Hypotension, Systemic Inflammatory Response Syndrome, Lobar Pneumonia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Prilosec; Colace; Prozac; Fentanyl; Potassium Chloride; Vicodin; Iron; Atenolol; Synthroid; Warfarin Sodium



Possible Velcade side effects in

Reported by a physician from United Kingdom on 2012-07-10

Patient:

Reactions: Off Label Use, Dyspnoea, Hypotension, Chest Pain, Pleural Effusion, Troponin Increased, Pyrexia, Myocardial Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Bendroflumethiazide; Codeine Sulfate; Dexamethasone; Gabapentin; Ibuprofen; Bisacodyl; Acetaminophen; Pamidronate Disodium; Amitriptyline HCL; Diazepam; Enoxaparin; Tramadol HCL



Possible Velcade side effects in

Reported by a physician from Ireland on 2012-07-09

Patient:

Reactions: Hypotension, Autonomic Neuropathy, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Difene; Allopurinol; Oxycontin; Zimovane



Possible Velcade side effects in 17 year old male

Reported by a physician from United States on 2012-07-09

Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)

Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Acute Respiratory Distress Syndrome, Pulmonary Oedema

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: 1000 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Daunorubicin Hydrochloride
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-26



Possible Velcade side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-06

Patient:

Reactions: Death, Dehydration, Hypotension, Mental Status Changes, Clostridial Infection, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone

Revlimid
    Administration route: Oral

Velcade



Possible Velcade side effects in 76 year old male

Reported by a physician from Japan on 2012-07-03

Patient: 76 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Off Label Use, C-Reactive Protein Increased, Interstitial Lung Disease, Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Levofloxacin
    Indication: C-Reactive Protein Increased
    Start date: 2012-04-16

Levofloxacin
    Start date: 2012-06-04

Velcade
    Start date: 2012-05-14
    End date: 2012-06-04

Velcade
    Indication: Multiple Myeloma
    Start date: 2012-03-27
    End date: 2012-04-17

Velcade
    Start date: 2012-03-06
    End date: 2012-03-16

Other drugs received by patient: Decadron; Decadron; Decadron



Possible Velcade side effects in

Reported by a physician from Serbia on 2012-06-29

Patient:

Reactions: Malaise, Hyperpyrexia, Hypoproteinaemia, Diarrhoea, Hypotension, Pseudomembranous Colitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriablastin
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-11-23
    End date: 2012-03-01

Amikacin

Dexamethasone
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-11-23
    End date: 2012-03-01

Meropenem

Vancomycin

Velcade
    Dosage: 1.3 mg, unk
    Indication: Multiple Myeloma
    End date: 2012-03-01

Other drugs received by patient: Diunorm; Losartan Potassium; Norvasc; Pantoprazole



Possible Velcade side effects in male

Reported by a pharmacist from United States on 2012-06-29

Patient: male, weighing 21.3 kg (46.9 pounds)

Reactions: B-Cell Lymphoma, Hypotension, Alanine Aminotransferase Increased, Pancytopenia, Roseolovirus Test Positive, Aspartate Aminotransferase Increased, Venoocclusive Liver Disease, Acute Respiratory Distress Syndrome, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Product Used FOR Unknown Indication

Fludarabine Phosphate
    Indication: Product Used FOR Unknown Indication

Mesna
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B-Cell Lymphoma
    Start date: 2011-12-27
    End date: 2012-01-16



Possible Velcade side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28

Patient: 65 year old female, weighing 78.9 kg (173.6 pounds)

Reactions: Hypotension, Anaemia, Electrolyte Imbalance, Thrombocytopenia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-01
    End date: 2012-06-18

Velcade
    Dosage: 1 milligram
    Indication: Multiple Myeloma
    Start date: 2011-11-30
    End date: 2012-04-30



Possible Velcade side effects in 76 year old male

Reported by a physician from Japan on 2012-06-28

Patient: 76 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Off Label Use, Lung Disorder, C-Reactive Protein Increased, Hypotension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Levofloxacin
    Start date: 2012-06-04

Levofloxacin
    Indication: C-Reactive Protein Increased
    Start date: 2012-04-16

Velcade
    Start date: 2012-05-14
    End date: 2012-06-04

Velcade
    Start date: 2012-03-06
    End date: 2012-03-16

Velcade
    Indication: Multiple Myeloma
    Start date: 2012-03-27
    End date: 2012-04-17

Other drugs received by patient: Decadron; Decadron; Decadron



Possible Velcade side effects in 62 year old female

Reported by a physician from United States on 2012-06-27

Patient: 62 year old female, weighing 62.0 kg (136.4 pounds)

Reactions: Pneumonia Fungal, Blood Alkaline Phosphatase Increased, Dyspnoea, Hypotension, Febrile Neutropenia, Muscular Weakness, Hypokalaemia, Dehydration, Hypoxia, Hypoalbuminaemia, Pulmonary Oedema, Neutrophil Count Decreased, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06



Possible Velcade side effects in 72 year old female

Reported by a consumer/non-health professional from United States on 2012-06-21

Patient: 72 year old female, weighing 59.0 kg (129.7 pounds)

Reactions: Vomiting, Fatigue, Nausea, Urinary Tract Infection, Dehydration, Hypotension, Systemic Inflammatory Response Syndrome, Lobar Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in

Reported by a physician from France on 2012-06-18

Patient:

Reactions: Electrocardiogram QT Prolonged, Back Pain, Death, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29



Possible Velcade side effects in male

Reported by a individual with unspecified qualification from France on 2012-06-18

Patient: male

Reactions: Diarrhoea, Anaemia, Hypotension, Leukaemia Plasmacytic, Paraesthesia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2011-08-29
    End date: 2011-12-30

Velcade
    Start date: 2011-08-29
    End date: 2011-12-30

Other drugs received by patient: Levothyroxine Sodium; Atacand; Nicardipine Hydrochloride



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017